Massachusetts Financial Services’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
22,408
-54,386
| -71% | -$443K | ﹤0.01% | 874 |
|
|
2025
Q1 | $603K | Sell |
76,794
-1,750
| -2% | -$13.7K | ﹤0.01% | 838 |
|
|
2024
Q4 | $1.17M | Sell |
78,544
-2,345
| -3% | -$34.9K | ﹤0.01% | 806 |
|
|
2024
Q3 | $1.24M | Buy |
80,889
+22,716
| +39% | +$347K | ﹤0.01% | 779 |
|
|
2024
Q2 | $886K | Buy |
58,173
+1,951
| +3% | +$29.7K | ﹤0.01% | 804 |
|
|
2024
Q1 | $1.06M | Sell |
56,222
-124
| -0.2% | -$2.34K | ﹤0.01% | 781 |
|
|
2023
Q4 | $1.08M | Sell |
56,346
-1,780
| -3% | -$34K | ﹤0.01% | 766 |
|
|
2023
Q3 | $1.04M | Sell |
58,126
-2,227
| -4% | -$40K | ﹤0.01% | 759 |
|
|
2023
Q2 | $1.23M | Sell |
60,353
-1,422
| -2% | -$28.9K | ﹤0.01% | 734 |
|
|
2023
Q1 | $1.13M | Buy |
+61,775
| New | +$1.13M | ﹤0.01% | 747 |
|